The effect of various well-characterized heparin preparations on the inactivation of human Factor XIa by human antithrombin III was studied. The 
INTRODUCTION
Human Factor XIa is the proteinase that links the contact phase of blood coagulation to intrinsic Factor X activation. It is a dimeric molecule, which is composed of two heavy chains (Mr 50000) and two light chains (Mr 33000) held together by disulphide bonds (Bouma & Griffin, 1977) . It is the only known dimeric enzyme participating in blood coagulation, and the light chain of each monomer contains an active site (Fujikawa et al., 1986) .
Antithrombin III is one of the four plasma proteinase inhibitors that have been reported to inactivate Factor XIa (Scott et al., 1982) . Both active sites in Factor XIa interact with antithrombin III (Kurachi & Davie, 1977) , and we have shown that the two sites are inhibited independently of each other both in the absence and in the presence of heparin (Soons et al., 1987) . Heparin is a mixture of mucopolysaccharides that is heterogeneous with respect to Mr, charge density and affinity to antithrombin III. In a previous study we have shown that the rate of inactivation of Factor XIa by antithrombin III is a direct measure for the binding of antithrombin III to heparin (Soons et al., 1987) . The mechanism via which the heparin-induced rate enhancement for bound antithrombin III is brought about remains, however, to be established. Holmer et al. (1981) reported that the rate enhancement of Factor XIa inhibition by antithrombin III at a single heparin concentration is dependent upon the Mr of the heparin. However, more recently Beeler et al. (1986) (Nesheim, 1983) , with unfractionated heparin as a standard. The molar concentrations were calculated by using the average Mr as indicated in Table 1 .
Proteins
Human Factor XI was purified by the method of Bouma et al. (1983) . Human Factor XII was isolated as described by Griffin & Cochrane (1976) . Human antithrombin III was purified as described by Thaler & Schmer (1975) . fl-Factor XIIa was prepared from purified Factor XII as described by Fujikawa & McMullen (1983) . Factor XI, Factor XII and antithrombin III preparations were homogeneous and pure as determined by gel electrophoresis in the presence of SDS on 10 % polyacrylamide gels according to the procedure of Laemmli (1970) . The specific activities determined in a clotting assay for Factors XI and XII were 211 and 74 units/mg respectively, assuming 1 unit to be present per ml of normal human plasma. All proteins were stored at -70°C after dialysis against 175 mM-NaCl/50 mmTris/HCl buffer, pH 7.9, for human antithrombin III and 150 mM-NaCI/0.5 mM-EDTA/4 mM-sodium citrate/ 2 mM-acetic acid buffer, pH 5.0, for human Factors XI and XII.
Preparation of human Factor XIa
Preparation of human Factor XIa from human Factor XI by using human fl-Factor XIIa was performed as described previously (Soons et al., 1986) . Factor XIa was separated from fl-Factor XIIa on a DEAE-Sephadex column (1.5 x 11.5 cm) at 4°C in 150 mM-NaCl/50 mmTris/HCl buffer, pH 8.0. Amidolytic activity of human Factor XIa was measured with the chromogenic substrate S2366 in 175 mmNaCl/20 mM-EDTA/50 mM-Tris/HCl buffer, pH 7.9, containing 0.5 mg of human serum albumin/ml. The kinetic parameters of the hydrolysis of the chromogenic substrate S2366 by human Factor XIa were Km= 0.42 mM and kcat = 758 s-5.
Protein concentration
Protein concentrations were routinely determined by the method of Bradford (1976) . Factor XIa concentrations were expressed as 80000-Mr subunits (van der Graaf et al., 1983) . Antithrombin III concentration was measured by employing an Alm, 280 value of 5.7 (Kurachi & Davie, 1977) and by a titration against a known concentration of human thrombin.
Kinetic data analysis
In a previous study we showed that the inactivation of Factor XIa by antithrombin III, both in the absence and in the presence of heparin, can be fully described according to a mechanism in which both active sites in Factor XIa are inhibited independently of each other with the same rate constant of inhibition. Furthermore, it was shown that the stimulation of the reaction rate in the presence of heparin can be.satisfactorily explained by the binding of antithrombin III to heparin (Soons et al., 1987) . Therefore in a first approximation the data obtained in the present study with different heparin preparations were also analysed by assuming that the stimulation of the reaction rate in the presence of heparin was due to antithrombin III binding. In that case the reaction can be written as:
in which XIa is the 80000-Mr subunit of Factor XIa and in which AT-Illf and AT-IlIb are free antithrombin III and antithrombin III bound to heparin respectively. k1 and k2 are the rate constants of inactivation by free antithrombin III and by the antithrombin III-heparin complex. The rate equation can be written as:
(2) and the slope of a pseudo-first-order plot will equal -(k-[AT-IIIf]+ k2 -[AT-IIIbI). k1 and k2 can be independently determined in the absence of heparin (all antithrombin III is free) and in the presence of saturating amounts of heparin (all antithrombin III is bound). Since also the total amount of antithrombin III is known, the amounts of bound antithrombin III and of free antithrombin III can be calculated.
It should be stressed that in the above it is tacitly assumed that the equilibrium of binding of antithrombin III to heparin is not influenced by Factor XIa or by products formed during the reaction. Since the inactivation of Factor XIa remained pseudo-first-order throughout and since the binding data obtained were independent of the amounts of Factor XIa present over the whole range of Factor XIa concentrations tested (0.1-200 nM), this assumption appears to hold.
Binding of antithrombin III to heparin
The parameters (Kd and amounts of binding sites) of antithrombin III binding to heparin were obtained by determination of the rate of inactivation of Factor XIa by antithrombin III in the presence of heparin at various concentrations of heparin and antithrombin III. From the slopes of the pseudo-first-order plots the amounts of free antithrombin III and of antithrombin III bound to heparin were calculated as described above by using the independently determined k1 and k2. The binding constant Kd is given as: the data obtained pseudo-first-order plots were constructed, and the rate constant, k, was obtained from the slope of these plots by linear regression of the data, using at least six time points for each determination. The standard error in the rate constants thus obtained was less than 1.5 %. Panel (a) shows the changes in the pseudo-first-order reaction rate constant, k, when Factor XIa (8 nM) and antithrombin III (0.16 #M) were titrated with unfractionated heparin (range 0.06-11.6 /LM) (@ symbols). The rate constant in the absence of heparin is given by a A symbol. Panel (b) shows the changes in the pseudo-first-order rate reaction constant, k, when Factor XIa (8 nM) and unfractionated heparin (0.28 #M) were titrated with antithrombin III (range 0.05-1.01tM) (@). The same experiment was also performed in the absence of heparin (A). kinetic data analysis, because both experiments should give the same Kd for a given heparin preparation, and the calculated total antithrombin III concentration should of course be equal to the amount of antithrombin III added to the reaction mixture.
RESULTS AND DISCUSSION
The inhibition of human Factor XIa by human antithrombin III was studied in the presence of different heparins by measurement of the disappearance of Factor XIa amidolytic activity towards the chromogenic substrate S2366. The experiments presented here were performed several times on separate days with essentially the same results, and representative experiments are shown. Under all conditions tested the inactivation of Factor XIa was pseudo-first-order in Factor XIa since semi-logarithmic plots of the residual activity versus time yielded straight lines. From such plots the apparent firstorder reaction rate constants (k) were obtained. Fig. l(a) shows a saturation curve obtained when the apparent first-order rate constant of inhibition of Factor XIa (8 nM) by antithrombin III (0.16 jsM) was determined as a function of the heparin concentration (0.06-1 1.6,/M). Fig. l(b) shows the pseudo-first-order reaction rate constants obtained when at constant concentrations of Factor XIa (8 nM) and heparin (0.28 ,UM) the concentration of antithrombin III was varied (0.05-1.0/M). In the latter case the rate constant did not reach a plateau (0 symbols), because the rate of Factor XIa inhibition in the absence of heparin was not negligible (A symbols).
The data of Fig. 1 can be analysed according to a mechanism in which the stimulation by heparin is assumed to be due to binding of antithrombin III to heparin (see the Materials and methods section). For this it is necessary that the rate constants of inactivation of Factor XIa by free antithrombin III (k,) and by antithrombin III bound to heparin (k2) are known. k, can be determined from the rate of Factor XIa inhibition in the absence of heparin (A symbols in Fig. 1 b) and k2 is obtained from the rate of Factor XIa inhibition at saturating heparin concentrations (plateau in Fig la) .
From the data shown in Fig. 1 k, was determined to be 1.0X 103x 1 S 1 and k2 was 29.6x 103I 1ss1.
By using these two rate constants the binding of antithrombin III was calculated at each heparin and antithrombin III concentration and plotted as described in the Materials and methods section to obtain the parameters of antithrombin III binding to heparin. (Fig. 2, 0 symbols) . This is in good agreement with the values reported in the literature (Jordan et al., 1979; Griffith, 1982 (Fig. 2, 0 Fig. 3(a) shows the saturation curves obtained when Factor XIa (8 nM) and antithrombin III (0.16 /M) were titrated with the four heparin fractions. Fig. 3(b) shows that when the antithrombin III concentration was varied (0.05-1.0/tM) the pseudo-first-order reaction rate constant increased more in the presence of the heparin fractions (@, A, U and * symbols) than in the absence of heparin (O symbols). The amounts of heparin chosen for the different fractions in the experiment presented in Fig. 3(b) was chosen such that the amounts of antithrombin III-binding sites were approximately equal. Thus, although the amounts of heparin present in each antithrombin III titration experiment was different, on a molar basis the amounts of antithrombin III-binding sites present were the same in each titration experiment presented in Fig. 3(b) . In all cases the stimulating effect of heparin increased in the order of fraction A < fraction B < fraction C < fraction D.
From the data shown in Fig. 3 (a) the rate constants of inhibition at saturating heparin concentration (k2) were obtained, and these are summarized in Table 2 . The binding of antithrombin III to fraction A caused a 7-fold increase in the rate constant compared with the rate constant obtained in the absence of heparin. Binding of antithrombin III to fraction D caused an acceleration of 41.2-fold.
From the data from experiments in which the antithrombin III concentrations were varied* at a given heparin concentration (Fig. 3b) the parameters of binding of antithrombin III to heparin were determined as described in the Materials and methods section. The results are also summarized in Table 2 . The calculated Kd values showed a 3-fold variation (280 nM-96 nM) whereas the number of antithrombin III-binding sites varied from 0.058 to 0.74 site per molecule of heparin. These data are in agreement with the data of Sache et al. (1982) , who also described an increase in antithrombin III-binding material from fraction A to fraction D. However, comparison of the data in Tables 1 and 2 shows that on a quantitative basis our fractions contained fewer antithrombin IlI-binding sites than expected on basis of the data originally reported by Sache et al. (1982) . This likely reflects some variability in the preparation of these fractions as well as some uncertainty in the Mr used to calculate the number of sites present per molecule of heparin for each fraction. By using the total amounts of sites as determined above the data in Fig.  3 (a) were also replotted as described in the Materials and methods section to obtain the binding parameters. From such plots the same Kd values were obtained (results not shown). Therefore, as described for the unfractionated heparin, both titration experiments yielded a set of internally consistent data. We therefore conclude that the inactivation of Factor XIa by antithrombin III in the presence of heparin can be satisfactorily explained in terms of the binding of antithrombin III to heparin.
However, the final magnitude of the rate constant obtained at saturating heparin concentration was dependent upon the type of heparin used (cf. Fig. 3a and The kinetic data given in this Table were calculated from the data presented in Figs. 1 and 3 according the analysis described in the Materials and methods section. The second-order reaction rate constant, k2, was calculated by using the data given in Fig. l(a) for the unfractionated heparin and the data given in Fig. 3(a) for the heparin fractions. The antithrombin III-heparin binding constants, Kd, and the number of antithrombin III binding sites per molecule of heparin were derived from the data given in Fig. 1(b) for the unfractionated heparin and from the data given in Fig. 3(b) At this moment at least two possibilities remain to explain the observations reported in this paper. First, it is possible that the inactivation of Factor XIa is solely dependent upon the binding of antithrombin III and that no interactions between heparin and Factor XIa contribute to the observed reaction rate. This so-called allosteric reaction model of activation of antithrombin III by heparin has been proposed (Jordan et al., 1979) . However, in such a model our data can only be accommodated if one assumes that the change in antithrombin III upon binding to heparin differs for each different type of heparin. A second explanation is that Factor XIa-heparin interactions influence the rate of inactivation of Factor XIa by antithrombin III bound to heparin. Such a possibility is supported by the observation that Factor XIa has affinity for heparin-Sephadex (Osterud & Rapaport, 1977) . However, direct binding experiments of Factor XIa binding to the different types of heparins will be needed to gain more insight into this question.
